Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2020/1643 of 5 November 2020 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances calcium phosphide, denathonium benzoate, haloxyfop-P, imidacloprid, pencycuron and zeta-cypermethrin (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 216, Imidacloprid, the date is replaced by ‘1 December 2020’; (2) in the sixth column, expiration of approval, of row 226, Denathonium benzoate, the date is replaced by ‘1 December 2020’; (3) in the sixth column, expiration of approval, of row 261, Calcium phosphide, the date is replaced by ‘1 December 2020’; (4) in the sixth column, expiration of approval, of row 281, Zeta-cypermethrin, the date is replaced by ‘1 December 2020’; (5) in the sixth column, expiration of approval, of row 309, Haloxyfop-P, the date is replaced by ‘31 December 2020’; (6) in the sixth column, expiration of approval, of row 349, Pencycuron, the date is replaced by ‘31 May 2021’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.